Answers are grounded in this paper and cite their sources.
CHD risk in acromegalic patients, predicted by FS as in nonacromegalic subjects, is low; AS might have adjunctive role only in a subset of patients. However, most patients have systemic complications of acromegaly, which participate in the assessment of global CHD risk.
No takes yet. Share an insight, caveat, or question.
Bogazzi et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: